InvestorsObserver
×
News Home

Is it Time to Dump Meridian Bioscience Inc (VIVO) Stock After it Has Risen 0.39% in a Week?

Tuesday, January 10, 2023 03:09 PM | InvestorsObserver Analysts

Mentioned in this article

Is it Time to Dump Meridian Bioscience Inc (VIVO) Stock After it Has Risen 0.39% in a Week?

Meridian Bioscience Inc (VIVO) stock is up 0.39% over the past week and gets a Bullish rating from InvestorsObserver Sentiment Indicator.

Sentiment Score - ,bullish
Meridian Bioscience Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on VIVO!

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With VIVO Stock Today?

Meridian Bioscience Inc (VIVO) stock is trading at $33.58 as of 2:53 PM on Tuesday, Jan 10, a rise of $0.01, or 0.01% from the previous closing price of $33.57. Volume today is elevated. So far 748,222 shares have traded compared to average volume of 571,510 shares. The stock has traded between $33.50 and $33.60 so far today.

More About Meridian Bioscience Inc

Meridian Bioscience Inc is an integrated life science company. It develops and distributes diagnostic tests and reagents, as well as biologic substances used by pharmaceutical and biotechnology companies. Its Diagnostics segment manufactures tests primarily for gastrointestinal, viral, respiratory, & parasitic infectious diseases. Its testing platforms include isothermal DNA amplification, rapid immunoassays, and enzyme-linked immunoassays. The Life sciences segment sells b-antigens, antibodies, and reagents in bulk to other diagnostic manufacturers, the agriculture industry, and researchers. It also manufactures proteins that biopharmaceutical companies use in new drugs and vaccines. The entity has a business presence in the US and other countries. Click Here to get the full Stock Report for Meridian Bioscience Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App